Stacie Hanes, APRN
Gerontology · Oklahoma City, OKNPI 1497364699
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Edwards Lifesciences at 49.2% of the total. Reporting peaked in 2023 at $2,893 and has fallen 88.2% since, to $342 in 2025. Among gerontology clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $114.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$3K
- Medtronic$2K
- Ancora Heart, Inc.$261
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$221
- Abiomed$207
- Alnylam Pharmaceuticals Inc.$123
- plus $47 from 1 others
What the payments were for
- Speaking & faculty fees$84013%
- Travel & lodging$3,15549%
- Food & beverage$2,40337%
- Education$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 25 | $3,165 |
| Medtronic | 18 | $2,403 |
| Ancora Heart, Inc. | 2 | $261 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $221 |
| Abiomed | 2 | $207 |
| Alnylam Pharmaceuticals Inc. | 1 | $123 |
| Corcept Therapeutics | 1 | $47 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$1,947
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,674
- AccuCinch$238
- Impella$158
- AMVUTTRA$123
How this compares
$6,426 in reported general payments places this provider in the 90th percentile of 73 gerontology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 41 | $24,837 |
| EliquisApixaban | 40 | $22,456 |
| ClopidogrelClopidogrel Bisulfate | 64 | $1,282 |
| Potassium Chloride | 27 | $458 |
| Amlodipine Besylate | 15 | $312 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 13 | $182 |
| Carvedilol | 16 | $116 |
| Furosemide | 24 | $59 |
| Metoprolol Tartrate | 13 | $53 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Oklahoma City
- Whitney SimmonsOklahoma City$40K
- Christy CovingtonOklahoma City$12K
- Christine ReithOklahoma City$5K
- Ashley NixOklahoma City$4K
- Anita BhandariOklahoma City$4K
- Hannah GoodspeedOklahoma City$3K
- Blaine WhitsonOklahoma City$2K
- Amber GarretsonOklahoma City$1K
- Mildred TwumOklahoma City$952
- Bart BurdickOklahoma City$938
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.